{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:17:51Z","timestamp":1792189071196,"version":"4.4.0"},"reference-count":25,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":541,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Many individuals with heartburn self\u2010medicate with antacids for relief of their symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To compare efficacy of effervescent ranitidine to as\u2010needed calcium carbonate antacids in subjects who self\u2010treat heartburn.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A total of 155 subjects with frequent antacid\u2010responsive heartburn were randomized to receive effervescent ranitidine 150\u2003mg tablets b.d., or as\u2010needed calcium carbonate 750\u2003mg for 12\u2003weeks. Endoscopic oesophagitis severity and mucosal histology were assessed at baseline, and at weeks 6 and 12. Heartburn frequency, severity, and antacid consumption were recorded daily, and quality of life was assessed at baseline, and at weeks 6 and 12.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Heartburn frequency and severity were significantly decreased after 1\u2003day of ranitidine (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.02). By week 6, ranitidine had significantly decreased rescue antacid consumption (7.3 tablets, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) vs. antacids (14.1 tablets). Endoscopic oesophagitis healing (\u2264\u2003grade 1) was significantly better with ranitidine (55%, <jats:italic>P<\/jats:italic>=0.022) vs. antacids (29%). Quality of life was improved by both treatments; however, ranitidine was numerically superior for all quality of life parameters, statistically superior for several quality of life indices at week 6 and for the pain\u2010related index by week 12 (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>For subjects self\u2010administering antacids for chronic heartburn, effervescent ranitidine 150\u2003mg b.d. is more effective than antacids in reducing heartburn, healing erosive oesophagitis, alleviating pain, and improving quality of life.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00785.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:41:29Z","timestamp":1047354089000},"page":"911-918","source":"Crossref","is-referenced-by-count":22,"title":["Managing heartburn at the \u2018base\u2019 of the GERD \u2018iceberg\u2019: effervescent ranitidine 150 mg b.d. provides faster and better heartburn relief than antacids"],"prefix":"10.1111","volume":"14","author":[{"family":"Earnest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Rodriguez\u2010Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ciociola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kleoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Murdock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)33219-6"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109667"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212163072503"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197305032881801"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01308159"},{"key":"e_1_2_6_7_2","first-page":"1570","article-title":"Comparison of tablet and liquid antacids on acidity in the esophagus and stomach","volume":"90","author":"Chelikani S","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199506000-00007"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199508000-00006"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.1987.00370080123022","article-title":"Ranitidine therapy for gastroesophageal reflux disease. Results of large double\u2010blind trial","volume":"147","author":"Sontag S","year":"1987","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.21.2373"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatments with omeprazole","volume":"95","author":"Hetzel DJ","year":"1985","journal-title":"Gastroenterology"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90349-2"},{"key":"e_1_2_6_14_2","first-page":"A203","article-title":"Effervescent ranitidine 150\u2003mg and standard ranitidine 150\u2003mg both relieve heartburn within 30\u2003minutes of dosing","volume":"110","author":"Murdock RH","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_6_15_2","first-page":"697","article-title":"Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide","volume":"85","author":"Orr WC","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.1987.00370080123022","article-title":"Ranitidine therapy for gastroesophageal reflux disease","volume":"147","author":"Sontag S","year":"1987","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_17_2","first-page":"9","article-title":"Ranitidine in the treatment of symptomatic gastroesophageal reflux disease","volume":"6","author":"Sherbaniuk R","year":"1984","journal-title":"J Clin Gastroenterol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.24.10.921"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1983.tb122676.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199020"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609011116"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.11.1523"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609011128"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0889-8553(21)00664-6","article-title":"The medical management of reflux esophagitis","volume":"19","author":"Sontag SJ","year":"1990","journal-title":"Gastroent Clin North Am"},{"key":"e_1_2_6_25_2","first-page":"141","article-title":"Endoscopic findings in patients with heartburn who have not sought medical advice","volume":"5","author":"Johnson CD","year":"1992","journal-title":"Hellenic J Gastroenterol"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309096056"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00785.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00785.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00785.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:53:07Z","timestamp":1698565987000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00785.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00785.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00785.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}